GAFFX
Price
$75.94
Change
+$0.68 (+0.90%)
Updated
Dec 23 closing price
MAPPX
Price
$23.07
Change
-$0.09 (-0.39%)
Updated
Dec 23 closing price
Ad is loading...

GAFFX vs MAPPX

Header iconGAFFX vs MAPPX Comparison
Open Charts GAFFX vs MAPPXBanner chart's image
American Funds Growth Fund of Amer F3
Price$75.94
Change+$0.68 (+0.90%)
VolumeN/A
CapitalizationN/A
Morgan Stanley Inst Advantage A
Price$23.07
Change-$0.09 (-0.39%)
VolumeN/A
CapitalizationN/A
GAFFX vs MAPPX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GAFFX vs. MAPPX commentary
Dec 24, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GAFFX is a Buy and MAPPX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
GAFFX has more cash in the bank: 301B vs. MAPPX (202M). GAFFX pays higher dividends than MAPPX: GAFFX (0.75) vs MAPPX (0.00). GAFFX was incepted earlier than MAPPX: GAFFX (8 years) vs MAPPX (15 years). MAPPX is a more actively managed with annual turnover of: 42.00 vs. GAFFX (31.00). MAPPX has a lower initial minimum investment than GAFFX: MAPPX (1000) vs GAFFX (1000000). MAPPX annual gain was more profitable for investors over the last year : 39.48 vs. GAFFX (21.26). GAFFX return over 5 years is better than : 51.30 vs. MAPPX (-8.05).
GAFFXMAPPXGAFFX / MAPPX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years15 years-
Gain YTD21.03140.39652%
Front LoadN/AN/A-
Min. Initial Investment10000001000100,000%
Min. Initial Investment IRAN/AN/A-
Net Assets301B202M149,010%
Annual Yield % from dividends0.750.00-
Returns for 1 year21.2639.4854%
Returns for 3 years3.63-28.82-13%
Returns for 5 years51.30-8.05-637%
Returns for 10 yearsN/A38.33-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KMDA6.050.15
+2.54%
Kamada Ltd
MFC30.630.30
+0.99%
Manulife Financial Corp
TGTX32.260.06
+0.19%
TG Therapeutics
OMCL44.50-0.48
-1.07%
Omnicell
ASRV2.58-0.15
-5.49%
AmeriServ Financial